With interest, we read the article of Hugo et al, who described a mortality of 8.7% in 46 solid organ transplant recipients after COVID-19 infection [1]. Because a misinterpretation may have detrimental implications for solid organ transplant recipients regarding COVID-19 vaccine prioritization, we think it is important to comment on the misleading title and the limitations of their conclusions due to an obvious selection bias in the control group.

In the Berlin-Brandenburg region, we serve an area of 6.1 million people and approximately 2500 kidney transplant recipients. Here, 209.960 cases of COVID-19 (3.4% of the total population) and 6002 deaths due to COVID-19 (2.9% of registered COVID-19 cases) were documented up to March 7 [2]. During the last year, we observed 114/2500 (4.6%) cases of COVID-19 in kidney transplant recipients and 10/114 (8.8%) deaths due to COVID-19. Hence, mortality was strikingly similar in our cohort compared to Hugo et al.[1] and lower as compared to previously described kidney transplant cohorts with mortality rates between 12% and